(Q41653508)

6 October 2017

1 reference

title

Health-related quality-of-life assessment and planning for the pharmaceutical industry (English)

1 reference

6 October 2017

1 reference

Revicki DA

1

1 reference

6 October 2017

Ehreth JL

series ordinal

2

1 reference

6 October 2017

publication date

1 September 1997

1 reference

6 October 2017

published in

Clinical Therapeutics

1 reference

6 October 2017

volume

19

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

1101-1115

1 reference

Shattuck lecture--outcomes management. A technology of patient experience

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Chronic disease, function and the quality of care

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Quality of life, health status, and clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Psychometric considerations in evaluating health-related quality of life measures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Utilities and quality-adjusted life years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Methods for assessing relative importance in preference based outcome measures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

A methodological framework for assessing health indices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

A quantitative approach to perceived health status: a validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Responsiveness and calibration of the General Well-Being Adjustment Scale in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Methodology for measuring health-state preferences--I: Measurement strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Methodology for measuring health-state preferences--II: Scaling methods

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Relationship between health utility and psychometric health status measures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Methodology for measuring health-state preferences--III: Population and context effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Preferences for health outcomes. Comparison of assessment methods

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Health status measures: an overview and guide for selection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

The validity of proxy-generated scores as measures of patient health status.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

Managed care pharmacy, socioeconomic assessments and drug adoption decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

The view from managed care pharmacy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980063-X

7 January 2021

10.1016/S0149-2918(97)80063-X

Identifiers

DOI

1 reference

6 October 2017

1 reference